Sixth Affiliated Hospital, Sun Yat-sen University: all 217 studies

Page 3 of 3. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using ThalidomideStatus unknownNCT02956538Early Phase 1
• Pre-genotype NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel DiseaseStatus unknownNCT02929706Not applicable
• Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical SurgeryStatus unknownNCT02796820Phase 3
• Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal CancerStatus unknownNCT02785146Phase 3
• Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal GastrectomyStatus unknownNCT02763878Phase 3
• Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal CancerStatus unknownNCT02630056
• Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant TherapyStatus unknownNCT02554448Not applicable
• The Efficiency of MSC in Refractory Crohn's DiseaseStatus unknownNCT02532738Phase 2/3
• DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal CancerStatus unknownNCT02415699Phase 2/3
• TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical TrailStatus unknownNCT02295592Not applicable
• Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric CancerStatus unknownNCT02289378Phase 2
• Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic TreatmentStatus unknownNCT02226289Phase 2
• Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to OxaliplatinStatus unknownNCT02087475Phase 3
• Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric CancerCompletedNCT01567618Phase 2
• Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer PatientsCompletedNCT01554059Phase 2
• Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric AdenocarcinomaStatus unknownNCT01552980Phase 2
• Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal AdenocarcinomaStatus unknownNCT01552967Phase 2

← Sixth Affiliated Hospital, Sun Yat-sen University overview and focus areas